Cell Culture Media Market Trends

Global Cell Culture Media Market Overview

Cell Culture Media Market size was valued at USD 3.85 billion in 2023. The Cell Culture Media Market industry is projected to grow from USD 4.39 billion in 2024 to USD 12.47 billion by 2032, exhibiting a compound annual growth rate (CAGR) of 13.92% during the forecast period (2024 - 2032).

The growth of the cell culture media market is attributed to the strategic initiatives to boost pharmaceutical R&D, cell culture media associated product launch & investment, and the increasing incidences of chronic diseases.

Source: Secondary Research, Primary Research, MRFR Database and Analyst Review

Cell Culture Media Trends

• Increasing incidences of chronic diseases fuels market growth

The rising prevalence of chronic diseases is increasing the demand for pharmaceutical products, which further increases the demand for cell culture media. As per the GLOBOCAN 2020, Asia accounted for the largest share (49.5%), followed by Europe (22.8%), North America (13.3%), Latin America and the Caribbean (7.6%), Africa (5.7%), and Oceania (1.3%). Moreover, according to the World Health Organization, approximately 50 million people diagnosed with epilepsy by February 2024, globally, which is the most common neurological disease across the globe. Furthermore, the Diabetes Atlas 2021 reported that the Western Pacific had 206 million, followed by Southeast Asia with 90 million, the Middle East and North Africa with 73 million, Europe with 61 million, North America and the Caribbean with 51 million, South and Central America with 32 million, and Africa with 24 million people with diabetes. Therefore, the high incidence of the above-mentioned diseases increases the demand for innovative drugs, which certainly leads to the R&D of products for such diseases, boosting the cell culture media market.

Cell Culture Media Segment Insights

Cell Culture Media Product Type Insights

The Cell culture supplements Market segmentation, based on product type, includes media and supplements. The media segment held the majority share in the market in 2022. The media segment is further sub-segmented into basal media, complex media, and serum-free while the supplements segment is sub-segmented into fetal bovine serum (FBS), newborn calf serum, horse serum, and others. Cell culture media generally comprise an appropriate source of energy and compounds which regulate the cell cycle. Stem cell culture is used for stem cell research and drug discovery processes that include cancer research, drug testing and development, and regenerative and cell-based therapies. Serum-Free Media (SFM) helps researchers to grow a specific cell type in the culture media. The presence of serum in the media sometimes misinterprets in immunological studies. These media are specifically formulated to boost the culture of a single cell type, such as knockout Dulbecco's Modified Eagle Medium (DMEM) and knockout serum replacement. It is also used in the production of monoclonal antibodies (MAbs). Thermo Fisher Scientific provides HyClone Products, such as CCM1q, PF-MAbq, and SFX-MAbq. CCM1 is serum-free media product in the market.

Cell Culture Media Application Insights

The Cell Culture Media Market segmentation, based on application, includes regenerative medicine, biopharmaceutical production, and research. The biopharmaceutical production segment dominated the market in 2022. Biopharmaceutical production is the production of biologics-based therapeutic drugs, including protein-based therapeutics, vaccines, gene therapies, and cell therapies. Cell cultures form the base for the Biopharmaceutical production of many large molecule-based drugs, vaccines, and cellular therapies where cell culture media is used.

Figure 2: Cell Culture Media Market, by Application, 2024 & 2032 (USD Billion)

Source: Secondary Research, Primary Research, MRFR Database and Analyst Review

Cell Culture Media Cell Type Insights

The Cell Culture Media Market segmentation, based on cell type, includes animal cells, plant cells, and bacterial cells. The bacterial cells segment dominated the market in 2022. The bacterial cultures are used for recombinant protein expression, plasmid cloning and amplification, and bacterial artificial chromosome (BAC) and cosmid cloning. Bacterial cells can be altered to uptake and incorporate exogenous genes and plasmids through transformation.

Cell Culture Media Regional Insights

By Region, the study segments the market into North America, Europe, Asia-Pacific, and Rest of the World. The North America cell culture suppliments market accounted for the largest market share in 2022. North America is attributed to the presence of major manufacturers, the increasing prevalence of diseases leading to the high demand for drugs and other medications, technological advancements in the preclinical and clinical segment, increasing awareness among the population, and high disposable income. The American Cancer Society, Inc. stated that 1.9 million new cancer cases were diagnosed and 609,360 cancer deaths in the US. Thus, this increasing patient pool will enhance market growth during the forecast period.

Further, the major countries will be study are US, Canada, Germany, France, UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil.

Figure 3: CELL CULTURE MEDIA MARKET BY REGION 2022 & 2032 (USD Billion)

Source: Secondary Research, Primary Research, MRFR Database and Analyst Review

Europe cell culture suppliments market accounted for the second-largest market share due high disposable income per individual and increased healthcare spending. Furthermore, the Germany cell culture media provider attributed to hold the largest market share, and the France cell culture media providers is projected be the fastest growing market in the Europe region.

The Asia-Pacific cell culture media market is expected to be the fastest growing from 2024 to 2032 due to the presence of many research organizations, low manufacturing cost, low labor cost, developing healthcare infrastructure, and increased investments by the American and European market giants in Asian countries such as China and India are likely to drive the demand for cell culture media in the Asia-Pacific region. Moreover, China cell culture suppliments accounted to hold the largest market share, and the India cell culture media is projected to be the fastest growing market in the Asia-Pacific region.

Cell Culture Media Key Market Players & Competitive Insights

The Cell Culture Media Market has been continuously growing owing to factors such as strategic initiatives to boost pharmaceutical R&D, increasing incidences of chronic diseases, cell culture media associated product launch & investment for research and development for oncology, neurology, and immunology drugs. The market has been distinguished by the presence of numerous global, regional, and local players to meet their customers' demands. Moreover, market participants are implementing several business strategies to strengthen their position in the marketplace. They are investing heavily in R&D to diversify their cell culture media product portfolio and expand the cell culture media market.

Thermo Fisher Scientific Inc. (US) specializes in various biotechnology products such as analytical instruments, laboratory supply chain programmes and e-commerce, laboratory equipment, lab services, and specialty diagnostics. It helps its customers solve complex analytical challenges, accelerate life sciences research, improve patient diagnostics, deliver medicines to the market, and increase the productivity of the laboratory. It has five premier brands: Thermo Scientific, Applied Biosystems, Invitrogen, Unity Lab Services, and Fisher Scientific. It offers combination of purchasing convenience, innovative technologies, and comprehensive services. It provides a wide range of media, reagents, plastics, instruments, and equipment for cell culture.

It is distributing its products in the following countries: Argentina, Brazil, Canada, Chile, Mexico, the US, Australia, China, India, Japan, Malaysia, New Zealand, Singapore, South Korea, Austria, Belgium, Czech Republic, Denmark, France, Germany, Israel, Italy, Netherlands, Spain, the UAE, the UK, Sweden, and Switzerland, among others.

Moreover, In January 2022, Thermo Fisher Scientific, Inc. (US) acquired PeproTech (US) to broader cell culture applications, especially for use in cellular research models. This acquisition complemented Thermo Fisher’s cell culture media products and will persistently assist in offering integrated products associated with the cell culture media.

Key Companies in the cell culture media market includes.

• Thermo Fisher Scientific Inc. (US)


• Sartorius AG (Germany)


• Merck KGaA (Germany)


• Danaher Corporation (US)


• Lonza (Switzerland)


• Becton, Dickinson and Company (US)


• HiMedia Laboratories (India)


• Corning Incorporated (US)


• Promocell GmbH (Germany)


• Bio-Rad Laboratories, Inc. (US)

Cell Culture Media Industry Developments

March 2023:Sartorius AG (Germany) acquired Polyplus (France) in order to offer an innovative solution that will complement Sartorius cell culture media business and create lucrative growth opportunities.

August 2022:Thermo Fisher Scientific, Inc. (US) expanded its cell culture media manufacturing site in Grand Island, New York (US) in order to meet increasing demand for cell culture media. This expansion is helping meet the demand of its customer while also preparing for future growth and continuously improving its global customer experience.

January 2022:Thermo Fisher Scientific, Inc. (US) acquired PeproTech (US) to broaden cell culture applications, especially for use in cellular research models. This acquired complemented Thermo Fisher’s cell culture media products and will persistently assist in offering integrated products associated with the cell culture media.

November 2021:Merck KGaA (Germany) signed strategic agreement with GI Innovation (South Korea) to facilitate biomedicine development in Korea. Through the mutual agreement, Merck will support GI Innovation with technologies and services including CHOZN platform, cell culture media, and overall process consulting and technical support.

October 2019:Thermo Fisher Scientific, Inc. (US) introduced a cell culture medium that can remain stable at room temperature, provides greater flexibility, and requires less energy. Moreover, this product reduces Thermo Fisher’s carbon footprints and makes the world cleaner.

Cell Culture Media Segmentation

Cell Culture Media Product Type Outlook

• 
  Media 
  
  
  
  • 
    Basal Media
    
    
    
    • Dulbecco's Modified Eagle Medium (DMEM)
    
    
    • Minimum Essential Medium (MEM)
    
    
    • Others
    
    
    
    
  
  
  • Complex Media
  
  
  • Serum-Free
  
  
  • CHO
  
  
  • Stem Cell
  
  
  • Others
  
  
  
  


• 
  Supplements 
  
  
  
  • Fetal Bovine Serum (FBS)
  
  
  • Newborn Calf Serum
  
  
  • Horse Serum
  
  
  • Others
  
  
  
  

Cell Culture Media Application Outlook

• Regenerative Medicine 


• 
  Biopharmaceutical Production
  
  
  
  • Monoclonal Antibodies
  
  
  • Vaccines
  
  
  • Others
  
  
  
  


• Research

Cell Culture Media Cell Type Outlook

• Animal Cells 


• Plant Cells 


• Bacterial Cells

Cell Culture Media Regional Outlook

• 
  North America
  
  
  
  • US
  
  
  • Canada
  
  
  
  


• 
  Europe
  
  
  
  • Germany
  
  
  • France
  
  
  • UK
  
  
  • Italy
  
  
  • Spain
  
  
  • Rest of Europe
  
  
  
  


• 
  Asia-Pacific
  
  
  
  • China
  
  
  • Japan
  
  
  • India
  
  
  • South Korea
  
  
  • Australia
  
  
  • Rest of Asia-Pacific
  
  
  
  


• 
  Rest of the World
  
  
  
  • Middle East
  
  
  • Africa
  
  
  • Latin America